SCHEMBL25565

SCHEMBL25565

C=CCC([C]=O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4425211 0.75
SCHEMBL28944916 0.71
SCHEMBL14993152 0.71
SCHEMBL27691179 0.71
SCHEMBL6559750 0.71
SCHEMBL1414891 0.71
SCHEMBL647294 0.71
SCHEMBL2658924 0.71
SCHEMBL680097 0.71
SCHEMBL236174 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708679-B1 PHARMACEUTICAL SPRAY FORMULATION COMPRISING A HYDRO FLUOR ALKANE AND AN ACYLATED CYCLODEXTRIN ASTRAZENECA AB (SE) 2008-11-12 EP claimed
US-20080124757-A1 DISCRETE ACYLTRANSFERASES ASSOCIATED WITH TYPE I POLYKETIDE SYNTHASES AND METHODS OF USE WISCONSIN ALUMNI RESEARCH FOUNDATION 2008-05-29 US claimed
CN-101087600-A Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin ASTRAZENECA AB (SE) 2007-12-12 CN claimed
US-20070104652-A1 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin ASTRAZENECA AB (SE) 2007-05-10 US claimed
EP-1708679-A2 PHARMACEUTICAL SPRAY FORMULATION COMPRISING A HYDRO FLUOR ALKANE AND AN ACYLATED CYCLODEXTRIN AstraZeneca AB (SE) 2006-10-11 EP claimed
WO-2005053637-A2 PHARMACEUTICAL SPRAY FORMULATION COMPRISING A HYPRO FLUOR ALKANE AMD AN ACYLATED CYCLODEXTRIN ASTRAZENECA AB (SE) 2005-06-16 WO claimed
US-20030175888-A1 Discrete acyltransferases associated with type I polyketide synthases and methods of use WISCONSIN ALUMNI RESEARCH FOUNDATION 2003-09-18 US claimed
CN-110643652-B Method for synthesizing quinolizinone compound by enzyme method 北京中医药大学 2021-05-11 CN disclosed
CN-111334500-A Method for preparing streptomyces strain with high tacrolimus yield by mutagenesis 浙江弘盛药业有限公司 2020-06-26 CN disclosed
CN-111334500-A Method for preparing streptomyces strain with high tacrolimus yield by mutagenesis 浙江弘盛药业有限公司 2020-06-26 CN disclosed
CN-110643652-A Method for synthesizing quinolizinone compound by enzyme method 北京中医药大学 2020-01-03 CN disclosed
CN-110251511-A The FK506 derivative and application thereof of the maintenance neuroregenerative activity of no immunosuppressive activity 尹特荣生物科技株式会社 2019-09-20 CN disclosed
CN-107683286-A Plasmepsin V structure compound with inhibitor and application thereof 沃尔特及伊莱萨霍尔医学研究院 2018-02-09 CN disclosed
US-20020111317-A1 Sixteen-membered macrolide compounds KOSAN BIOSCIENCES, INC. 2002-08-15 US disclosed
WO-2002032916-A2 SIXTEEN-MEMBERED MACROLIDE COMPOUNDS KOSAN BIOSCIENCES, INC. (US) 2002-04-25 WO disclosed
CN-1333820-A Recombinant methods and materials for producing epothilone and eopthilone derivatives KOSAN BIOSCIENCES INC (US) 2002-01-30 CN disclosed
US-6303342-B1 CULTURING CELL THAT CONTAINS NUCLEIC ACID CODING FOR EXPRESSION OF SORANGIUM CELLULOSUM EPOTHILONE POLYKETIDE SYNTHASE; ANTICARCINOGENIC AGENTS, FUNGICIDES, IMMUNOSUPPRESSANTS KASON BIOSCIENCES, INC. 2001-10-16 US disclosed
EP-0463707-A1 Production of polyketide antibiotics LUBRIZOL GENETICS INC. (US) 1992-01-02 EP disclosed
EP-0262154-A1 ISOLATION OF GENES FOR BIOSYNTHESIS OF POLYKETIDE ANTIBIOTICS LUBRIZOL GENETICS INC. (US) 1988-04-06 EP disclosed
WO-1987003907-A1 ISOLATION OF GENES FOR BIOSYNTHESIS OF POLYKETIDE ANTIBIOTICS LUBRIZOL GENETICS, INC. (US) 1987-07-02 WO disclosed